develop
broadrang
virusneutr
antibodi
bnab
requir
identifi
immunolog
target
conserv
among
target
virus
suitabl
antibodi
target
discoveri
oligomannosyl
moieti
target
bnab
stimul
substanti
interest
carbohydr
moieti
vaccin
candid
heavi
glycosyl
hiv
envelop
oligomannos
appear
defens
mechan
viru
evad
host
immun
recognit
proteinbas
neutral
epitop
howev
isol
number
glycandepend
hiv
bnab
hivinfect
individu
potent
bnab
strongli
suggest
glycan
shield
hiv
virion
may
also
display
import
target
immunolog
intervent
viral
infect
like
virtual
human
virus
decor
virion
carbohydr
moieti
thu
potenti
viral
carbohydr
immunolog
target
viral
pathogen
warrant
explor
one
intrigu
question
whether
human
virus
distinct
phylogenet
origin
sarscov
may
display
conserv
glycan
target
suitabl
broad
viru
neutral
avail
bnab
target
conserv
glycan
clearli
import
improv
biodefens
public
health
respons
unexpect
viral
epidem
respons
sar
epidem
team
introduc
carbohydr
microarray
studi
sarscovelicit
antiglycan
antibodi
essenc
character
carbohydratebind
activ
sarscovneutr
antibodi
elicit
immun
hors
inactiv
sarscov
vaccin
hors
antibodi
detect
unexpect
autoantibodi
reactiv
specif
carbohydr
moieti
abund
human
serum
glycoprotein
asialoorosomucoid
asor
target
carbohydr
triantennari
type
ii
multival
type
ii
trimii
sugar
moieti
nglycosyl
pathway
potenti
gener
numer
cryptic
nglycan
distinct
structur
characterist
spike
glycoprotein
sarscov
potenti
nlink
glycosyl
site
ritchi
et
al
determin
glycan
profil
spike
protein
produc
monkey
cell
major
glycan
includ
highmannos
hybrid
bi
tri
tetraantennari
complex
carbohydr
without
bisect
glcnac
core
fucos
interestingli
sialyl
neglig
spike
protein
produc
monkey
cell
led
exposur
termin
galactos
trimii
glycodetermin
thu
induct
antiasor
autoantibodi
inactiv
sarscov
attribut
fact
asor
sarscov
spike
glycoprotein
commonli
express
trimii
cryptic
glycodetermin
note
structur
glycom
studi
reveal
sarscov
also
express
highmannos
seri
carbohydr
structur
major
glycan
moieti
thu
despit
fact
two
virus
differ
gener
glycan
profil
commonli
overexpress
oligomannosyl
core
nglycan
signific
number
virusneutr
agent
target
oligomannosyl
moieti
notabl
includ
mab
lectin
gna
howev
two
probe
repres
distinct
class
virusneutr
agent
former
monospecif
latter
pauci
reactiv
potent
neutral
sever
virus
includ
least
hcmv
sarscov
given
spectrum
antiviru
activ
gna
may
serv
model
explor
broadspectrum
virusneutr
epitop
essenti
step
toward
goal
identifi
natur
ligand
gna
preserv
among
gnatarget
viral
pathogen
focu
studi
figur
b
examin
detect
gna
glycoprotein
preserv
nativ
glycoepitop
produc
two
prepar
cell
ie
express
cell
presenc
kifunensin
potent
inhibitor
follow
previous
describ
procedur
use
inhibitor
allow
enrich
highmannos
type
glycoform
block
glycosyl
process
complex
hybrid
carbohydr
thu
produc
resembl
nativ
envelop
spike
hiv
almost
entir
coat
oligomannos
antigen
protein
appli
elisa
plate
glycan
stain
perform
comparison
lectin
phaseolu
vulgarisl
lectin
phal
sambucu
nigra
agglutinin
snai
gna
target
oligomannosyl
epitop
phal
trimii
cryptic
epitop
snai
recogn
residu
panel
probe
monitor
express
layer
cryptic
glycoepitop
schemat
shown
figur
assay
demonstr
figur
figur
strongli
posit
gna
phal
select
reactiv
phaldifferenti
stain
pattern
reflect
effect
blockag
biosynthesi
trimii
complex
moieti
product
initi
plan
neg
glycoprotein
stain
condit
examin
whether
sarscov
express
nativ
gnaepitop
phalepitop
figur
elisa
plate
coat
nativ
sarscov
antigen
express
vero
cell
plate
treat
disinfect
fix
agent
gammairradi
inactiv
infecti
viru
particl
preserv
antigen
structur
sarscov
lectin
appli
concentr
specifi
figur
assay
demonstr
phalepitop
readili
detect
sarscovco
elisa
plate
previous
observ
moreov
show
gna
strongli
posit
sarscov
contrast
galgalnacreact
lectin
includ
helix
pomatia
hpa
griffonia
bandeiraea
simplicifoliai
gsi
margin
reactiv
sarscov
antigen
hpa
specif
galnac
oglcnacmoieti
gsi
recogn
latter
conserv
mani
microorgan
neglig
sarscov
expect
figur
examin
whether
hcmv
express
oligomannosyl
epitop
use
gna
concanavalin
con
comparison
lectin
differ
specif
experi
elisa
coat
purifi
viru
creativ
diagnost
new
york
ny
usa
protein
concentr
approxim
lectinscreen
two
antimannos
agent
differ
epitopebind
specif
gna
specif
moieti
oligomannos
con
recogn
termin
broadli
express
mannosecontain
antigen
figur
illustr
lectinbind
synthet
glycoconjug
bear
gna
conaglycoepitop
inspect
figur
readili
reveal
rel
bind
activ
gna
markedli
higher
cona
activ
hcmvelisa
assay
although
two
mannosespecif
lectin
similarli
reactiv
standard
assay
lectin
differ
glycanbind
specif
show
certain
reactiv
hcmv
lysat
may
reflect
glycom
complex
intric
human
viru
requir
studi
summari
verifi
express
nativ
gnaepitop
three
phylogenet
distinct
virus
sarscov
hcmv
context
panel
lectin
differ
specif
gna
identifi
highest
rel
bind
activ
sarscov
hcmv
abil
gna
bind
neutral
virus
distinct
phylogenet
origin
unavoid
rais
question
glycanbind
specif
potenti
crossreact
one
plausibl
explan
target
virus
commonli
express
defin
gnaepitop
moieti
howev
select
gnaposit
stain
hcmv
without
parallel
con
reactiv
figur
suggest
altern
possibl
ie
presenc
carbohydr
moieti
neg
weakli
reactiv
con
strongli
reactiv
gna
carbohydr
antigen
differenti
reactiv
gna
con
yeastderiv
phosphomannan
polysaccharid
pman
nevertheless
present
viral
glycom
support
explor
potenti
gna
glycoepitop
studi
produc
set
comprehens
antigen
microarray
includ
largepanel
carbohydr
lipidsliposom
protein
antigen
supplementari
tabl
key
compound
support
glycoepitop
analysi
includ
follow
orosomucoid
asor
trimii
agalactoor
agor
trimgn
figur
autoantigen
display
distinct
glycoepitop
ident
protein
carrier
asor
asialoderiv
agor
agalactoderiv
asor
crucial
defin
bindingspecif
nglycan
cryptic
epitop
trimii
trimgn
thiolat
keyhol
limpet
hemocyanin
klhsh
nklh
nklh
two
conjug
display
moieti
two
defin
cluster
configur
highli
specif
ribonucleas
b
rb
main
glycan
phosphomannan
pman
yeast
polysaccharid
pman
known
posit
gna
former
latter
also
bind
con
use
microarray
character
gna
phal
epitopebind
profil
result
summar
figur
figur
figur
schemat
view
structur
relationship
among
autoantigen
asor
agor
glycoepitop
display
figur
show
microarray
imag
phal
gna
stain
panel
autoantigen
includ
asor
agor
stand
nklh
conjug
two
control
probe
spot
klh
e
coli
polysaccharid
microarray
dataset
correspond
figur
shown
figur
illustr
antigen
spot
triplic
given
concentr
specifi
microarray
detect
shown
mean
fluoresc
intens
mfi
triplic
microspot
array
stain
phal
gna
respect
result
compar
use
overlay
plot
mfi
stain
signal
blue
bar
versu
local
background
surround
antigen
microarray
red
bar
figur
e
show
phal
specif
asor
trimii
respect
expect
howev
gna
highli
select
bind
number
nglycan
cryptic
sugar
moieti
includ
agor
gnabind
agor
novel
observ
given
gna
bind
asor
trimii
differ
agor
trimgn
termin
galactos
result
demonstr
therefor
gna
like
specif
trimgnglycoepitop
agor
expos
termin
glcnac
moieti
figur
illustr
global
antigenbind
profil
gna
full
panel
antigen
prepar
microarray
result
plot
ratio
antigenspecif
signal
correspond
spot
background
read
ie
gna
agbg
agbg
assist
compar
analysi
bind
profil
gna
dataset
plot
scale
yaxi
posit
detect
label
number
graph
agor
pman
two
dilut
whole
dataset
graph
list
supplementari
tabl
microarray
analysi
gna
show
minim
crossrel
irrelev
antigen
illustr
strikingli
differ
glycanbind
profil
monospecif
expect
contrast
gna
pauci
reactiv
number
glycan
target
bind
spot
oligomannos
antigen
pman
attribut
known
gnaspecif
recognit
share
andor
moieti
howev
gnabind
agor
asor
indic
gna
also
specif
recogn
trimgnglycodetermin
display
agor
support
predict
fact
agor
asor
neg
antimannos
agent
includ
lectin
con
mab
polyclon
antisera
recogn
oligomannosyl
moieti
vari
cluster
configur
molecular
mechan
underli
gnarecognit
trimgndetermin
agor
yet
explor
highprecis
microarray
robot
pixsi
cartesian
technolog
irvin
ca
usa
use
spot
antigen
prepar
onto
glass
slide
precoat
nitrocellulos
polym
fast
slide
schleicher
schuell
keen
nh
usa
describ
antigen
prepar
appli
includ
carbohydr
proteinspeptid
liposom
variou
composit
list
supplementari
tabl
protein
carbohydr
dissolv
phosphatebuff
salin
pb
ph
salin
nacl
respect
liposom
prepar
suspend
salin
nacl
concentr
specifi
print
triplic
spot
size
interv
center
center
print
microarray
airdri
store
room
temperatur
without
desicc
applic
immedi
use
print
microarray
rins
pb
ph
vv
tween
block
incub
slide
wv
bovin
serum
albumin
bsa
pb
contain
wv
room
temperatur
rt
min
incub
rt
nih
aid
reagent
program
germantown
md
usa
biotinyl
phal
phalbi
gnabi
ey
laboratori
inc
san
mateo
ca
usa
indic
titrat
wv
bsa
pb
contain
wv
vv
tween
secondari
antibodi
streptavidin
conjug
appli
microarray
stain
specifi
figur
legend
stain
slide
rins
five
time
pb
vv
tween
airdri
room
temperatur
scan
fluoresc
signal
use
microarray
scanner
perkinelm
life
scienc
boston
usa
follow
manufactur
manual
fluoresc
intens
valu
array
spot
background
calcul
use
scanarray
express
softwar
perkinelm
life
scienc
boston
usa
sa
institut
jmpgenom
softwar
packag
cari
nc
usa
use
microarray
data
process
statist
analysi
figur
microarray
detect
shown
mean
fluoresc
intens
mfi
triplic
detect
captur
scanarray
array
stain
phal
gna
analysi
microarray
data
associ
visual
inspect
microarray
imag
provid
evalu
reproduc
variat
antigen
microarray
technolog
figur
microarray
result
plot
ratio
antigenspecif
signal
correspond
spot
background
read
ie
gna
agbg
agbg
whole
microarray
dataset
phal
gna
present
supplementari
tabl
two
prepar
produc
cell
previous
describ
express
presenc
inhibitor
kifunensin
enrich
highmannos
type
glycoform
prepar
sucros
densitygradientpurifi
hcmv
obtain
creativ
diagnost
ny
ny
usa
elisa
protocol
describ
previous
detect
anticarbohydr
antibodi
follow
minor
modif
figur
antigen
prepar
dilut
sodium
bicarbon
buffer
solut
ph
coat
elisa
micropl
nunc
maxisorp
thermo
fisher
scientif
inc
santa
clara
ca
usa
follow
block
use
bsa
pbst
figur
sarscovspecif
elisa
kit
euroimmun
ag
germani
use
measur
sarscovexpress
lectinspecif
glycoepitop
antiglycan
antibodi
biotinyl
lectin
pretitr
bsa
pbst
elisa
bound
antibodi
reveal
alkalin
phosphatas
ap
conjug
goat
antihuman
iggfcspecif
antibodi
biotinyl
lectin
captur
quantifi
apstreptavidinconjug
pilot
studi
examin
whether
human
virus
distinct
phylogenet
origin
may
express
common
carbohydr
moieti
use
carbohydr
microarray
elisabas
viral
glycanprofil
analysi
character
two
broadli
hivneutr
agent
human
monoclon
antibodi
lectin
gna
although
agent
known
target
oligomannosyl
antigen
differ
strikingli
spectrum
virus
effect
neutral
former
sole
hivspecif
latter
broadli
reactiv
human
virus
includ
sarscov
hcmv
phylogenet
pathogen
distinct
carbohydr
microarray
analys
demonstr
two
probe
differ
strikingli
glycantarget
specif
spectrum
glycoepitop
recogn
although
strictli
specif
highdens
cluster
decor
hiv
envelop
spike
gna
recogn
number
nglycan
cryptic
sugar
moieti
includ
oligomannos
previous
unrecogn
trimgnglycodetermin
latter
appear
potent
natur
ligand
gna
molecular
mechan
underli
gnamodel
pauci
reactiv
glycanbind
broad
virusneutr
warrant
investig
owe
potenti
immunogen
activ
plantderiv
lectin
gna
unlik
suitabl
antiviru
therapi
vivo
thu
effort
must
also
made
establish
gnalik
potent
broadli
virusneutr
antibodi
especi
human
fulli
human
mab
readili
applic
frontlin
biodefens
emerg
viral
pathogen
